Intercept Pharmaceuticals

Intercept Pharmaceuticals is a biopharmaceutical company dedicated to developing and delivering novel medicines for patients with rare and serious liver diseases. They have a strong focus on primary biliary cholangitis (PBC), a rare autoimmune liver disease, and are currently investigating new treatments for severe alcohol-associated hepatitis (sAH). Intercept has a diverse and growing pipeline based on novel scientific targets with the potential for therapeutic application across multiple liver diseases, with their lead compound being obeticholic acid (OCA), the first and only FDA-approved FXR agonist for the second-line treatment of PBC.

Intercept prides itself on a collaborative and innovative culture, with a team of passionate and hard-working individuals who are committed to making a difference in the lives of patients. The company emphasizes the importance of patient-centricity and their commitment to research and development is evident in their ongoing clinical trials and expanded access programs. They are dedicated to advancing their pipeline for liver diseases with high unmet need, reflecting their dedication to revolutionizing the treatment landscape for those living with chronic liver diseases.

Intercept Pharmaceuticals offers a hybrid working model, blending the flexibility of virtual work with the opportunity to return to the office and reconnect with colleagues. The company is committed to fostering a work-life balance for its employees, providing new options and demonstrating the effectiveness of a flexible approach to work.

Intercept Pharmaceuticals offers a comprehensive Total Rewards package designed to support employee well-being and success both inside and outside of work. This includes competitive financial benefits like base salaries, annual bonuses, and retirement savings plans, robust health and well-being incentives like medical, dental, and vision plans, disability support, and flexible spending accounts, and social and cultural programs that foster a work-life balance through team-building activities, peer recognition, and other initiatives.

Intercept Pharmaceuticals is a biopharmaceutical company focused on developing and delivering novel medicines to improve the lives of people with rare and serious liver diseases. Their mission is driven by a commitment to building a healthier tomorrow for these patients through innovative research, collaboration, and a dedication to patient-centricity.

Intercept Pharmaceuticals promotes a dynamic and fast-paced culture that values collaboration, integrity, excellence, innovation, passion, and patient-centricity. They foster an environment where entrepreneurial spirit thrives, individuality is embraced, and employees are encouraged to be self-motivated leaders. The company's commitment to diversity, equity, and inclusion ensures that all team members feel welcomed, respected, and valued for their contributions.

Intercept Pharmaceuticals is committed to fostering a diverse, equitable and inclusive work environment where all individuals feel valued, respected, and empowered to contribute to the company's mission. Their approach to diversity, equity, and inclusion focuses on welcoming individuals with different perspectives, encouraging self-motivated leaders at all levels, and investing in employees to help them define their own career paths.